Dual Mode of Action of a Human Anti-Epidermal Growth Factor Receptor Monoclonal Antibody for Cancer Therapy-Reference-Cited by-同舟云学术

Dual Mode of Action of a Human Anti-Epidermal Growth Factor Receptor Monoclonal Antibody for Cancer Therapy

Published:2004-09-21 Issue:7 Volume:173 Page:4699-4707
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

Bleeker Wim K.,Lammerts van Bueren Jeroen J.,van Ojik Heidi H.,Gerritsen Arnout F.,Pluyter Marielle,Houtkamp Mischa,Halk Ed,Goldstein Joel,Schuurman Janine,van Dijk Marc A.,van de Winkel Jan G. J.,Parren Paul W. H. I.

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference33 articles.

1. Prevalence of aberrant expression of the epidermal growth factor receptor in human cancers

2. Epidermal growth factor-related peptides and their receptors in human malignancies

3. ErbB-targeted therapeutic approaches in human cancer

4. Inhibitors of epidermal-growth-factor receptors: a review of clinical research with a focus on non-small-cell lung cancer

5. Signaling antibodies in cancer therapy

Cited by 136 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current status and perspective of tumor immunotherapy for head and neck squamous cell carcinoma;Frontiers in Cell and Developmental Biology;2022-08-26

2. Avidity in antibody effector functions and biotherapeutic drug design;Nature Reviews Drug Discovery;2022-07-05

3. Biophysical Characterization and Stability of Modified IgG1 Antibodies with Different Hexamerization Propensities;Journal of Pharmaceutical Sciences;2022-06

4. Epidermal Growth Factor Receptor as Target for Perioperative Elimination of Circulating Colorectal Cancer Cells;Journal of Oncology;2022-01-07

5. Regulation of CD38 on Multiple Myeloma and NK Cells by Monoclonal Antibodies;International Journal of Biological Sciences;2022